MAN2A1 and hepatocellular carcinoma: This year, investigators developed a novel screening method that combines serum levels of characteristic fusion gene transcription found in HCC (specifically MAN2A1-FER and CCNH-C5orf30 levels) with AFP, producing a 95% accurate early detection of HCC using serum analysis alone.